Regulations

FDA FDA Approval Drug Safety Drug Approval Medicare Licensing Medical Devices Medical Procedures Therapeutic Goods Administration Safety Standards

Nearly 370,000 Bottles of Duloxetine Recalled for Nitrosamine Impurity

Detection of N‑nitroso‑duloxetine above FDA interim limits signals manufacturing quality problems that could increase long‑term cancer risk.

Federal Agencies Reshape No Surprises Act IDR With Lower Fees and Wider Batching

Aveanna Completes $175.5 Million Cash Purchase of Family First Homecare

CMS Halts New Medicare Enrollment for Home Health and Hospice Nationwide

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Weight-Loss Drugs

Online Marketplaces Remove Melatonin Listings in UK After Which? Flags Illegal Sales

MHRA Launches Free Guidance to Help People Assess Mental Health Apps

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

Police Shut Down Illegal Coslada Aesthetic Clinic Over Expired Botox, Detain Owner

Chinese Weight-Loss Drug Suppliers Pivot to Generics as U.S. Crackdown Ends Copycat Boom

UK Confirms 41 Botulism Cases Linked to Unlicensed Cosmetic Injections

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

Medline Recalls 1.5 Million Bed Rails After Asphyxiation Deaths

Medline Recalls 1.5 Million Bed Rails After Entrapment Deaths

FTC Implements Nationwide Ban on Non-Compete Agreements

FDA Implements New Regulations on Laboratory Developed Tests

Biogen's Alzheimer's Drug Leqembi Exceeds Sales Expectations

Illinois Health Officials Issue Warning After Counterfeit Botox Injections Lead to Hospitalizations

Priory Healthcare Fined £650,000 for Safety Failings After Patient's Death